Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shujiro Inoue

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Hypertension (Dallas, Tex. : 1979)|November 2, 2002
Antiinflammatory and antiarteriosclerotic effects of pioglitazoneMinako Ishibashi, Kensuke Egashira, Ken-ichi Hiasa, et al.
Circulation|May 19, 2004
Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularizationKen-ichi Hiasa, Minako Ishibashi, Kisho Ohtani, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 9, 2004
Essential role of vascular endothelial growth factor and Flt-1 signals in neointimal formation after periadventitial injuryQingwei Zhao, Kensuke Egashira, Ken-ichi Hiasa, et al.
Journal of Cardiovascular Electrophysiology|March 4, 2024
Paced QRS morphology mimicking complete left bundle branch block induced by right ventricular pacing is associated with pacing-induced cardiomyopathyShota Ikeda, Kazuo Sakamoto, Masafumi Sugawara, et al.
Hypertension (Dallas, Tex. : 1979)|February 16, 2002
Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in ratsChu Kataoka, Kensuke Egashira, Shujiro Inoue, et al.
Circulation|November 20, 2002
Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout miceShujiro Inoue, Kensuke Egashira, Weihua Ni, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2004
Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic miceWeihua Ni, Shiro Kitamoto, Minako Ishibashi, et al.
Basic Research in Cardiology|April 17, 2004
Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factorKen-ichi Hiasa, Kensuke Egashira, Shiro Kitamoto, et al.
Plos One|April 25, 2022
Intra-atrial activation pattern is useful to localize the areas of non-pulmonary vein triggers of atrial fibrillationKazuo Sakamoto, Yasushi Mukai, Shunsuke Kawai, et al.
Circulation|March 6, 2002
Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesisQingwei Zhao, Kensuke Egashira, Shujiro Inoue, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Hypertension (Dallas, Tex. : 1979)|November 2, 2002
Antiinflammatory and antiarteriosclerotic effects of pioglitazoneMinako Ishibashi, Kensuke Egashira, Ken-ichi Hiasa, et al.
Circulation|May 19, 2004
Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularizationKen-ichi Hiasa, Minako Ishibashi, Kisho Ohtani, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 9, 2004
Essential role of vascular endothelial growth factor and Flt-1 signals in neointimal formation after periadventitial injuryQingwei Zhao, Kensuke Egashira, Ken-ichi Hiasa, et al.
Journal of Cardiovascular Electrophysiology|March 4, 2024
Paced QRS morphology mimicking complete left bundle branch block induced by right ventricular pacing is associated with pacing-induced cardiomyopathyShota Ikeda, Kazuo Sakamoto, Masafumi Sugawara, et al.
Hypertension (Dallas, Tex. : 1979)|February 16, 2002
Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in ratsChu Kataoka, Kensuke Egashira, Shujiro Inoue, et al.
Circulation|November 20, 2002
Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout miceShujiro Inoue, Kensuke Egashira, Weihua Ni, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2004
Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic miceWeihua Ni, Shiro Kitamoto, Minako Ishibashi, et al.
Basic Research in Cardiology|April 17, 2004
Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factorKen-ichi Hiasa, Kensuke Egashira, Shiro Kitamoto, et al.
Plos One|April 25, 2022
Intra-atrial activation pattern is useful to localize the areas of non-pulmonary vein triggers of atrial fibrillationKazuo Sakamoto, Yasushi Mukai, Shunsuke Kawai, et al.
Circulation|March 6, 2002
Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesisQingwei Zhao, Kensuke Egashira, Shujiro Inoue, et al.
Pageof 6